NLRP3 and hepatocellular carcinoma: The activation of NLRP3 has been shown to promote the secretion of α-SMA and type I collagen as well as other fibrosis markers to promote liver fibrosis, thus promoting the occurrence of hepatocellular carcinoma (Li et al., 2019).